Archive for March 2017

American Health Care Act would strongly affect and potentially worsen treatment and care for people living with HIV

March 14, 2017

Press release from AIDS United

AIDS United opposes the American Health Care Act as released by House Republicans on March 6th. The American Health Care Act would, if passed, strongly affect and potentially worsen treatment and care for people living with HIV and the provision of HIV prevention services for people at risk for infection. AIDS United works toward an end to the HIV epidemic by reaching outcomes described in the National HIV/AIDS Strategy and the many state-specific efforts to curb and finally end the epidemic. These outcomes include reducing HIV incidence, increasing access to care and improving health outcomes for people living with HIV, and reducing HIV-related health disparities.

The American Health Care Act undermines these goals. The replacement of premium subsidies with refundable tax credits will hurt the ability of low income people, including people living with HIV, to afford up-front payment of health plan premiums. Under this system thousands of people will lose coverage. These people will then be subject to a 30 percent penalty in their future cost of coverage because of continuous coverage requirements. These same requirements will hurt people who lose their jobs and will also make it more difficult for people to change jobs or move across the country. The bill also places a higher cost burden on older Americans by allowing higher premium as people age. This will result in much higher costs and lower access to care for lower income people. Finally, the bill effectively repeals Medicaid expansion in under three years at the end of 2019. Such a repeal will result in a loss of health coverage for millions of Americans, including people living with HIV and other chronic conditions.

Read the full press release.

Find PrEP providers in your area with the PrEP Locator

March 3, 2017

From m4mHealthSex.org

There’s a lot of research now regarding PrEP (Pre-Exposure Prophylaxis) and how taking this daily anti-viral medication can keep you from becoming infected with HIV. The problem is that most gay men don’t want to ask their doctor about it and don’t know how else they can get it.

truvadaBut now you can use a free online tool called PrEP Locator to find PrEP providers near you. The locator is a national directory of providers that you can search by entering your zip code. It’s also accessible on your smart phone as well as your computer.

Note too that in some cases, providers can also help with the cost of PrEP.

PrEP Locator is presented by Emory University, in partnership with M•A•C AIDS Fund.

If you live in the Pittsburgh area, you can also find local resources here.

For more information about PrEP and how it can help protect you from becoming infected with HIV, go to our Website: https://m4mhealthysex.org/what-is-prep/.

 

 

NASTAD: People living with HIV on antiretroviral therapy (ART) do not transmit the virus

March 1, 2017

From LGBTweekley.com

nastad-300x195WASHINGTON, D.C. – NASTAD (National Alliance of State & Territorial AIDS Directors), a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world, published a new statement affirming that durably virally suppressed people living with HIV on antiretroviral therapy (ART) do not sexually transmit the virus. The statement accelerates NASTAD’s longstanding work to end HIV and promote policies and public health practice grounded in science.

”The science is clear that people living with HIV with a sustained undetectable viral load do not transmit the virus to others. What’s also clear is that we have the tools to end the HIV epidemic and HIV-related stigma and make new infections a thing of the past. Today, we tackle a major part of this work by raising awareness about the latest science of HIV transmission risk,” remarked NASTAD Executive Director Murray Penner.

Read the full article.